Document Detail


Hand-foot syndrome with sclerodactyly-like changes in a patient treated with capecitabine.
MedLine Citation:
PMID:  18360124     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Capecitabine, a fluoropyrimidine carbamate with antineoplastic activity, is an oral agent that was developed as a prodrug of 5-fluorouracil and is used in the treatment of metastatic colorectal and breast cancers. Multiple cutaneous adverse effects had been described with the use of this drug, but to our knowledge, specific association with capecitabine and hand-foot syndrome with sclerodactyly-like changes has been described only once. We report a patient with a colon adenocarcinoma who presented with hand-foot syndrome, with sclerodactyly-like changes induced by capecitabine.
Authors:
Felicidade Trindade; Rosario Haro; Maria Carmen Fariña; Luis Requena
Related Documents :
3098924 - Intracranial calcified deposits in neurofibromatosis.
20199414 - The h syndrome.
9642614 - Pregnancy complicated by autoimmune polyglandular syndrome type ii: a case report.
9122064 - Pigmentary anomalies in the multiple lentigines syndrome: is it distinct from leopard s...
7754754 - A case report of stevens-johnson syndrome with mycoplasma pneumoniae infection.
15895274 - An overview of the patient with ataxia.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The American Journal of dermatopathology     Volume:  30     ISSN:  1533-0311     ISO Abbreviation:  Am J Dermatopathol     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-03-24     Completed Date:  2008-04-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7911005     Medline TA:  Am J Dermatopathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  172-3     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Hospital dos Capuchos, Lisbon, Portugal. felicidade.trindade@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / drug therapy,  secondary
Administration, Oral
Biopsy, Needle
Deoxycytidine / adverse effects,  analogs & derivatives*,  therapeutic use
Dose-Response Relationship, Drug
Fluorouracil / adverse effects,  analogs & derivatives*,  therapeutic use
Follow-Up Studies
Hand Dermatoses / chemically induced*,  pathology
Humans
Immunohistochemistry
Liver Neoplasms / drug therapy,  secondary
Male
Middle Aged
Scleroderma, Localized / chemically induced*,  pathology*
Severity of Illness Index
Sigmoid Neoplasms / drug therapy,  pathology
Syndrome
Chemical
Reg. No./Substance:
154361-50-9/capecitabine; 51-21-8/Fluorouracil; 951-77-9/Deoxycytidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Panniculitis as the initial manifestation of brucellosis: a case report.
Next Document:  An unusual composite pilomatrix carcinoma with intralesional melanocytes: differential diagnosis, im...